Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.32
(0.36%)
CNY 8.32
(0.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.75 Billion CNY | -34.99% |
| 2022 | 4.21 Billion CNY | 43.92% |
| 2021 | 2.92 Billion CNY | -23.7% |
| 2020 | 3.83 Billion CNY | 63.0% |
| 2019 | 2.35 Billion CNY | 16.03% |
| 2018 | 2.02 Billion CNY | 18.49% |
| 2017 | 1.71 Billion CNY | 9.82% |
| 2016 | 1.55 Billion CNY | -1.71% |
| 2015 | 1.58 Billion CNY | 5.05% |
| 2014 | 1.5 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 830.16 Million CNY | 11.91% |
| 2024 Q3 | 863.05 Million CNY | 4.61% |
| 2024 Q1 | 741.8 Million CNY | 1.3% |
| 2023 Q3 | 591.56 Million CNY | -3.35% |
| 2023 Q2 | 612.07 Million CNY | -24.87% |
| 2023 Q1 | 814.64 Million CNY | -28.75% |
| 2023 FY | 2.73 Billion CNY | -34.99% |
| 2023 Q4 | 732.31 Million CNY | 23.79% |
| 2022 Q2 | 1.14 Billion CNY | 14.94% |
| 2022 FY | 4.21 Billion CNY | 43.92% |
| 2022 Q4 | 1.14 Billion CNY | 22.58% |
| 2022 Q3 | 932.73 Million CNY | -18.28% |
| 2022 Q1 | 993.03 Million CNY | 65.98% |
| 2021 Q2 | 676.01 Million CNY | -17.62% |
| 2021 Q1 | 820.58 Million CNY | 10.03% |
| 2021 FY | 2.92 Billion CNY | -23.7% |
| 2021 Q4 | 598.3 Million CNY | -27.97% |
| 2021 Q3 | 830.65 Million CNY | 22.88% |
| 2020 FY | 3.83 Billion CNY | 63.0% |
| 2020 Q2 | 1.65 Billion CNY | 177.46% |
| 2020 Q4 | 745.75 Million CNY | -10.5% |
| 2020 Q1 | 597.55 Million CNY | -6.76% |
| 2020 Q3 | 833.21 Million CNY | -49.74% |
| 2019 Q4 | 640.88 Million CNY | 3.89% |
| 2019 Q2 | 580.56 Million CNY | 12.93% |
| 2019 Q1 | 514.1 Million CNY | -11.32% |
| 2019 FY | 2.35 Billion CNY | 16.03% |
| 2019 Q3 | 616.89 Million CNY | 6.26% |
| 2018 Q4 | 579.75 Million CNY | 6.26% |
| 2018 Q2 | 495.78 Million CNY | 22.0% |
| 2018 Q1 | 406.38 Million CNY | -7.23% |
| 2018 FY | 2.02 Billion CNY | 18.49% |
| 2018 Q3 | 545.58 Million CNY | 10.04% |
| 2017 Q4 | 438.07 Million CNY | 0.0% |
| 2017 FY | 1.71 Billion CNY | 9.82% |
| 2016 FY | 1.55 Billion CNY | -1.71% |
| 2015 FY | 1.58 Billion CNY | 5.05% |
| 2014 FY | 1.5 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 7.89 Billion CNY | 65.063% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3.36 Billion CNY | 18.087% |
| Blue Sail Medical Co.,Ltd. | 4.92 Billion CNY | 44.051% |
| Andon Health Co., Ltd. | 3.18 Billion CNY | 13.486% |
| Improve Medical Instruments Co., Ltd. | 644.62 Million CNY | -327.641% |
| Tofflon Science and Technology Group Co., Ltd. | 5.64 Billion CNY | 51.138% |
| Truking Technology Limited | 6.8 Billion CNY | 59.486% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 1.3 Billion CNY | -112.041% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 1.46 Billion CNY | -87.839% |
| Autek China Inc. | 1.73 Billion CNY | -58.687% |
| Intco Medical Technology Co., Ltd. | 6.91 Billion CNY | 60.156% |
| Jiangsu Apon Medical Technology Co., Ltd. | 417.98 Million CNY | -559.519% |
| Winner Medical Co., Ltd. | 8.18 Billion CNY | 66.321% |
| Imeik Technology Development Co.,Ltd. | 2.85 Billion CNY | 3.41% |
| Zhonghong Pulin Medical Products Co., Ltd. | 2.1 Billion CNY | -30.942% |
| Caina Technology Co., Ltd. | 410.47 Million CNY | -571.586% |